- Home
- ADTN vs MLTX Comparison
ADTN vs MLTX Comparison
Compare ADTN & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTN
- MLTX
- Stock Information
- Founded
- ADTN 1985
- MLTX 2021
- Country
- ADTN United States
- MLTX Switzerland
- Employees
- ADTN N/A
- MLTX N/A
- Industry
- ADTN Telecommunications Equipment
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- ADTN Telecommunications
- MLTX Health Care
- Exchange
- ADTN Nasdaq
- MLTX Nasdaq
- Market Cap
- ADTN 708.5M
- MLTX 595.6M
- IPO Year
- ADTN 1994
- MLTX N/A
- Fundamental
- Price
- ADTN $9.05
- MLTX $9.12
- Analyst Decision
- ADTN Strong Buy
- MLTX Buy
- Analyst Count
- ADTN 5
- MLTX 9
- Target Price
- ADTN $12.80
- MLTX $37.63
- AVG Volume (30 Days)
- ADTN 1.4M
- MLTX 11.8M
- Earning Date
- ADTN 11-03-2025
- MLTX 11-06-2025
- Dividend Yield
- ADTN N/A
- MLTX N/A
- EPS Growth
- ADTN N/A
- MLTX N/A
- EPS
- ADTN N/A
- MLTX N/A
- Revenue
- ADTN $983,368,000.00
- MLTX N/A
- Revenue This Year
- ADTN $17.80
- MLTX N/A
- Revenue Next Year
- ADTN $8.37
- MLTX N/A
- P/E Ratio
- ADTN N/A
- MLTX N/A
- Revenue Growth
- ADTN 3.52
- MLTX N/A
- 52 Week Low
- ADTN $6.02
- MLTX $5.95
- 52 Week High
- ADTN $12.44
- MLTX $62.75
- Technical
- Relative Strength Index (RSI)
- ADTN 47.69
- MLTX 24.88
- Support Level
- ADTN $8.40
- MLTX $8.18
- Resistance Level
- ADTN $9.54
- MLTX $10.95
- Average True Range (ATR)
- ADTN 0.32
- MLTX 0.90
- MACD
- ADTN -0.01
- MLTX 0.39
- Stochastic Oscillator
- ADTN 48.94
- MLTX 62.63
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.